<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS103585</article-id>
<article-id pub-id-type="doi">10.1101/2020.11.03.366666</article-id>
<article-id pub-id-type="archive">PPR234062</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Looking for pathways related to COVID-19 phenotypes: Confirmation of pathogenic mechanisms by SARS-CoV-2 - Host interactome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Messina</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giombini</surname>
<given-names>Emanuela</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Montaldo</surname>
<given-names>Chiara</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharma</surname>
<given-names>Ashish Arunkumar</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Piacentini</surname>
<given-names>Mauro</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zoccoli</surname>
<given-names>Antonio</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sekaly</surname>
<given-names>Rafick-Pierre</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Locatelli</surname>
<given-names>Franco</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zumla</surname>
<given-names>Alimuddin</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maeurer</surname>
<given-names>Markus</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Capobianchi</surname>
<given-names>Maria R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Lauria</surname>
<given-names>Francesco Nicola</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Ippolito</surname>
<given-names>Giuseppe</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<on-behalf-of>COVID 19 INMI Network Medicine for IDs Study Group</on-behalf-of>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Rome, Italy</aff>
<aff id="A2">
<label>2</label>Department of Biology, University of Rome "Tor Vergata," Rome, Italy</aff>
<aff id="A3">
<label>3</label>Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA</aff>
<aff id="A4">
<label>4</label>National Institute of Nuclear Physics, Rome, Italy</aff>
<aff id="A5">
<label>5</label>Department of Pediatric Hematology and Oncology IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy</aff>
<aff id="A6">
<label>6</label>Department of Infection, Division of Infection and Immunity, University College London, and National Institutes of Health and Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK</aff>
<aff id="A7">
<label>7</label>Champalimaud Centre for the Unknown, Lisbon, Portugal; I Medical Clinic, University of Mainz, Germany</aff>
<author-notes>
<corresp id="CR1">
<bold>Correspondence:</bold> Giuseppe Ippolito MD, FRCP, National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, Italy. <email>giuseppe.ippolito@inmi.it</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>05</day>
<month>11</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>03</day>
<month>11</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">CC BY-NC 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">In the last months, many studies have clearly described several mechanisms of SARS-CoV-2 infection at cell and tissue level. Host conditions and comorbidities were identified as risk factors for severe and fatal disease courses, but the mechanisms of interaction between host and SARS-CoV-2 determining the grade of COVID-19 severity, are still unknown.</p>
<p id="P2">We provide a network analysis on protein–protein interactions (PPI) between viral and host proteins to better identify host biological responses, induced by both whole proteome of SARS-CoV-2 and specific viral proteins. A host-virus interactome was inferred on published PPI, using an explorative algorithm (Random Walk with Restart) triggered by all the 28 proteins of SARS-CoV-2, or each single viral protein one-by-one. The functional analysis for all proteins, linked to many aspects of COVID-19 pathogenesis, allows to identify the subcellular districts, where SARS-CoV-2 proteins seem to be distributed, while in each interactome built around one single viral protein, a different response was described, underlining as ORF8 and ORF3a modulated cardiovascular diseases and pro-inflammatory pathways, respectively. Finally, an explorative network-based approach was applied to Bradykinin Storm, highlighting a possible direct action of ORF3a and NS7b to enhancing this condition.</p>
<p id="P3">This network-based model for SARS-CoV-2 infection could be a framework for pathogenic evaluation of specific clinical outcomes. We identified possible host responses induced by specific proteins of SARS-CoV-2, underlining the important role of specific viral accessory proteins in pathogenic phenotypes of severe COVID-19 patients.</p>
</abstract>
<kwd-group>
<kwd>SARS-CoV-2 infection</kwd>
<kwd>Virus-host interactome</kwd>
<kwd>COVID-19</kwd>
<kwd>Pathogenesis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P4">Whilst COVID-19 predominantly affects the respiratory system, it is a multisystem disease, with a wide spectrum of clinical presentations from asymptomatic, mild and moderate, to severe, fulminant disease (<xref ref-type="bibr" rid="R1">1</xref>). Host conditions and comorbidities such as high age, obesity, diabetes, hypertension, organ damages, inflammation and coagulation dysfunctionality, were identified as risk factors for severe and fatal disease courses(<xref ref-type="bibr" rid="R2">2</xref>), but the mechanisms of interaction between host and SARS-CoV-2 that activate pathological pathways and determine severity, are still unknown.</p>
<p id="P5">In last months, many studies clearly described several mechanisms of SARS-CoV-2 infection at cell and tissue level. It was observed that the replication of SARS-CoV-2, as well as all +RNA viruses, occurs in the cytoplasm of the host cell, inducing a membrane rearrangement of rough endoplasmic reticulum (ER) membranes into double-membrane vesicles (<xref ref-type="bibr" rid="R3">3</xref>, <xref ref-type="bibr" rid="R4">4</xref>). Moreover, NSP8 along with NSP7 and NSP12, which yield the RNA polymerase activity of NSP8, are assembled into the replicase–transcriptase complex, that begins to generate anti-sense (-) genomic RNA molecules, templates for positive-sense genome (+) and mRNA transcripts (<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R6">6</xref>). During virus entry, a well-known process is the cleavage of S protein by Furin on the cell membrane, which lead to split S protein into two subunits, S1 and S2, which the last can interact with ACE2 (<xref ref-type="bibr" rid="R7">7</xref>, <xref ref-type="bibr" rid="R8">8</xref>). However, the SARS-CoV-2-host interaction is not restricted to local infection, but it triggers a systemic reaction, including the activation of the Bradykinin Storm, as described in many severe COVID-19 patients (<xref ref-type="bibr" rid="R9">9</xref>). Indeed, SARS-CoV-2 infection causes from one side a decrease of ACE level in the lung cells and, on the other side, an increase of ACE2 level, leading to increase Bradykinin level (<xref ref-type="bibr" rid="R9">9</xref>). Furthermore, microvascular injuries, due to systemic inflammatory response and endothelial dysfunction, were frequently found in severe COVID-19 patients (<xref ref-type="bibr" rid="R10">10</xref>). Increased circulating D-dimer concentrations, reflecting pulmonary vascular bed thrombosis with fibrinolysis, and elevated cardiac enzyme concentrations, linked to emergent ventricular stress induced by pulmonary hypertension, were associated to early features of severe pulmonary intravascular coagulopathy related to COVID-19 (<xref ref-type="bibr" rid="R11">11</xref>). Moreover, myocardial injuries were found to be linked to the risk of fatal outcome in COVID-19 patients (<xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R14">14</xref>). In 43% severe patients (21% of all COVID-19 patients) the myocardial injury was observed and a severe patient had a 4.74-fold increase in the risk of myocardial injury than non-severe patients (<xref ref-type="bibr" rid="R15">15</xref>). Although microvascular injuries and microthrombi formation frequently occurred in severe COVID-19 patients, the role of SARS-CoV-2 in this phenotype is not completely explained yet.</p>
<p id="P6">Recently, results of a meta-analysis study on interleukin-6 concentrations in patients with severe or critical COVID-19, pointed out that the systemic inflammatory profile of COVID-19 is distinct from that of non- COVID-19 ARDS, sepsis, and CAR T cell-induced cytokine release syndrome, and it might be involved in organ dysfunction in COVID-19, such as endovasculitis, direct viral injury and viral-induced immunosuppression (<xref ref-type="bibr" rid="R16">16</xref>).</p>
<p id="P7">Although many aspects of COVID-19 pathogenesis and mechanisms of SARS-CoV-2 have been investigated, only few papers describe the interactions among SARS-CoV-2 proteins by wet experiments. Physical associations in human cells, between SARS-CoV-2 proteins and human proteins, were found by affinity-purification mass spectrometry (AP-MS), identifying 332 high-confidence SARS-CoV-2-human protein-protein interactions (PPIs), highlighting an activation of innate immune pathways (<xref ref-type="bibr" rid="R17">17</xref>). Then, the influence of SARS-CoV-2 on transcriptome, proteome, ubiquitinome and phosphoproteome of a lung-derived human cell line, was described through a multi-omic approach. Such a multilevel representation highlighted autophagy mechanisms regulation by ORF3a and nsp6, the modulation of innate immunity by M, ORF3a and NS7b, and the Integrin-TGF-β-EGFR-RTK signalling perturbation by ORF8 of SARS-CoV-2 (<xref ref-type="bibr" rid="R18">18</xref>).</p>
<p id="P8">Virus–host interactome by computational approach has been applied to COVID-19 for drug repurposing (<xref ref-type="bibr" rid="R17">17</xref>), allowing the identification of new drug targets (<xref ref-type="bibr" rid="R19">19</xref>) and contributing to explain clinical manifestations (<xref ref-type="bibr" rid="R20">20</xref>, <xref ref-type="bibr" rid="R21">21</xref>). The structural information on SARS-CoV-2 proteins and their interactions with human proteins and other viral proteins, allowed to better understand the mechanisms of SARS-CoV-2 infection, also comparing it with SARS-CoV (<xref ref-type="bibr" rid="R22">22</xref>).</p>
<p id="P9">One of the most interesting models of SARS-CoV-2 – host interactions was carried out on Spike-receptor interactions in other Human Coronaviruses (H-CoV). This network-based analysis of H-CoV - host interaction has provided a theoretic model for H-CoV infections applicable to SARS-CoV-2 pathogenesis, revealing biologically and clinically relevant molecular targets of three H-CoV infections (<xref ref-type="bibr" rid="R23">23</xref>).</p>
<p id="P10">The interactome based on PPI and gene expression data, have been applied also to uncover the molecular origins of phenotypes of other complex diseases (<xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R25">25</xref>), in order to better define the mechanisms of COVID-19 pathogenesis.</p>
<p id="P11">The understanding of all mechanisms of SARS-CoV-2 infection also passes by overall visualization of biological reactions and pathways involved in COVID-19 and H-CoV infections. It can carry out on a disease map, such as COVID-19 Disease Maps, containing many diagrams about host molecular response during the infection (<xref ref-type="bibr" rid="R26">26</xref>–<xref ref-type="bibr" rid="R28">28</xref>).</p>
<p id="P12">In this context, defining the host response induced by specific viral proteins would be of great importance and can guide the identification of functional viral targets, helping to better define the pathologic phenotypes of the infection.</p>
<p id="P13">Here, we carry out a network analysis on PPI to better identify host biological response induced by SARS-CoV-2. Furthermore, the interactome analysis was applied to design network of SARS-CoV-2 - host proteins that could lead to a Bradykinin Storm. We used three different applications to identify interacting proteins: 200 proteins that interact closely with 28 SARS-CoV-2 proteins, 50 protein interactomes around each SARS-CoV-2 protein and 200 protein associated with KNG1, the pre-cursor of Bradykinin (BK).</p>
<p id="P14">In all three models, pathways associated with proteins were identified, including DNA damage/repair, TGF-β signalling, complement cascades (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
</sec>
<sec id="S2" sec-type="results">
<title>Results</title>
<sec id="S3">
<title>Interactions with whole proteome of SARS-CoV-2</title>
<p id="P15">To define the massive effect of SARS-COV-2 infection on the host cell, an interactome between the entire set of SARS-CoV-2 proteins and host was carried out. Observing the colours’ distribution, it is possible to distinguish three different areas, corresponding to as many subcellular districts, where SARS-CoV-2 proteins seem to be distributed (<xref ref-type="fig" rid="F1">Figure 2 a</xref>). In fact, N, nsp1, nsp4 and nsp15 are posed around nuclear proteins, while S, along with nsp5, nsp10, nsp12, nsp13, nsp14, nsp16, ORF1a and ORF9b, were among cytosolic and membrane proteins, at the bounder of the interactome. Protein M and many accessory and not-structural proteins (NS7b, nsp6, nsp7, ORF3a, ORF7a, ORF8, ORF10 and ORF14) are around mitochondrial and endoplasmic proteins.</p>
<p id="P16">We described the high values of betweenness centrality and degree for 9 host proteins: two proteins Multi-organelle Amyloid-beta precursor protein (APP) and dual-specificity protein phosphatase (PTEN); the membrane protein Sodium/potassium-transporting ATPase subunit alpha-1 (ATP1A1); two cytoplasmic proteins, 14-3-3 protein theta (YWHAQ) and Ubiquitin (UBC); two proteins of endoplasmic reticulum and Golgi apparatus, Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (ATP2A2) and Unconventional myosin-VI (MYO6); the mitochondrial ATP synthase subunit alpha (ATP5F1A); one nuclear receptor for export of RNAs, Exportin-1 (XPO1), suggesting their main role in this infection (<xref ref-type="supplementary-material" rid="SD1">S-Figure 1</xref>, <xref ref-type="supplementary-material" rid="SD1">S-Table 1</xref>). In order to further dissect the interactions with the entire proteome of SARS-CoV-2, enrichment analysis was carried out with WikiPathways and Kyoto Encyclopaedia of Genes and Genomes (KEGG) databases. WikiPathways gene enrichment analysis revealed biological pathways of DNA replication, ubiquitination and proteasome, with high significance (FDR &lt;0.01%). In addition, KEGG pathway enrichment analysis revealed DNA and RNA replication pathways as the most significant pathways (FDR &lt;0.01%), as well as signalling pathways and viral infection pathways (<xref ref-type="fig" rid="F2">Figure 2 b</xref>).</p>
</sec>
<sec id="S4">
<title>Host response induced by specific protein of SARS-CoV-2</title>
<p id="P17">To define the effect of specific viral proteins on host response, interactomes were built, choosing one specific viral protein as seed, imposing to find the 50 closest proteins. These analyses allowed to produce 28 restricted interactomes, which defined the strictest biological interactions associated to seed proteins both among human proteins and other viral proteins. In <xref ref-type="supplementary-material" rid="SD1">S- Figure 2</xref> the interactomes for structural proteins were reported, while in <xref ref-type="supplementary-material" rid="SD1">S- Figures 3 and 4</xref> the interactomes for accessory and non-structural proteins were plotted.</p>
<p id="P18">Most of the interactomes have few viral proteins into the reconstruct PPI network (i.e. M, nsp1, and ORF3a), while into other interactomes the viral seed protein shared own human target proteins with other viral proteins or interacts directly with other viral proteins, such as nsp3, nsp10, ORF6 and ORF10.</p>
<p id="P19">The lists of proteins for each reduced interactome were submitted to gene enrichment analysis on WikiPathways and KEGG pathway databases (<xref ref-type="supplementary-material" rid="SD1">S-table 2 and 3</xref>, respectively). For each single viral protein interactome, the top 5% with the smallest p values of gene enrichment analysis was selected, reporting for KEGG and WikiPathways in <xref ref-type="fig" rid="F3">Figure 3 a and b</xref>, respectively.</p>
<p id="P20">For KEGG database the gene enrichment analysis on interactomes of NS7b, ORF1a, ORF3a and ORF8 showed pathway clusters highly significant and consistent with possible pathogenic mechanisms, such as the activation of the complement and of the coagulative cascade, (<xref ref-type="bibr" rid="R29">29</xref>) and the TGF-β-dominated immune response (<xref ref-type="bibr" rid="R30">30</xref>). In particular, the NS7b interactome revealed SNARE interactions in vesicular transport pathway, describing the mechanisms of intracellular vesicle trafficking and secretion, as the most significant pathway among all interactome (FDR&lt; 0. 00001%). The ORF1a interactome revealed a cluster of pathways, composed by Adherents junction, Bacteria host infection mechanisms, Regulation of actin cytoskeleton and phagocytosis, all showing the direct involvement of this accessory proteins in viral entry in host cells (FDR &lt; 0. 001%). The ORF8 interactome showed a pathway cluster involving complement and coagulation cascades and cardiovascular pathology (FDR &lt; 0.3%). The ORF3a interactome revealed the TGF-β and Cytokine signalling, endocytosis and Vasopressin-regulation pathways (FDR &lt; 0.01%). From pathway point of view, Proteasome pathway was involved in interactome of M protein as well as for ORF7a, ORF8 (FDR &lt; 0.05%) (<xref ref-type="fig" rid="F3">Figure 3a</xref>). For WikiPathways database the gene enrichment analysis showed results consistent with KEGG gene enrichment for ORF1a, ORF3a and ORF8, and added new pathway cluster for nsp1 (FDR&lt; 0.00001%) with DNA replication and modification pathways (<xref ref-type="fig" rid="F3">Figure 3b</xref>).</p>
</sec>
<sec id="S5">
<title>Computational investigation on Bradykinin Storm in COVID-19</title>
<p id="P21">As the virus-host interactome has been efficient to describe the response to specific viral proteins, this method was applied to reconstruct the possible involvement of SARS-COV-2 proteins in triggering the Bradykinin Storm during the infection. In this case, Kininogen-1 (KNG1), precursor of bradykinin made by proteolysis cleavage, was considered as seed for RWR, imposing 200 closest proteins as limit to stop the algorithm. The resulting interactome showed NS7b, ORF3a, ORF8 and S as proximal to the seed protein, suggesting their role in the modulation of biological processes around Kininogen-1. Indeed, it would provide a direct influence of NS7b and ORF3a proteins to activation of BK. In fact, both NS7b and ORF3a interact with the same target, Endothelin Converter Enzyme (ECE1), and cell surface endopeptidase that converts big endothelin-1 to pressure peptide endothelin-1 (ET-1) and inactivates BK (<xref ref-type="fig" rid="F4">Figure 4a</xref>). The enrichment analysis on WikiPathways and Kyoto Encyclopaedia of Genes and Genomes (KEGG) databases revealed biological pathways of Complement and coagulation cascades (FDR &lt;0.000001%). Finally, to quantify the direct effect of S, ORF8, ORF3a, NS7b on Complement and coagulation cascades pathways, all proteins belonged to the most significantly enriched pathways, were highlighted on the interactome: Human Complement System WP2806 for WikiPathways (22 of 97 genes; adj P value 2.9E-21) and Complement and coagulation cascades for KEGG (24 of 79 genes; adj P value 5.96E-27). ORF8 showed the direct interactions with Fibrinogen alpha chain (FGA), described in both pathways, and Urokinase-type Plasminogen Activator (PLAU), Tissue-type Plasminogen Activator (PLAT) and Plasminogen activator inhibitor 1 (SERPINE1).</p>
</sec>
</sec>
<sec id="S6" sec-type="discussion">
<title>Discussion</title>
<p id="P22">In this study, we built a functional interactome between SARS-CoV-2 and human proteome through RWR algorithm, to identify biological mechanisms and cell responses during SARS-CoV-2 infection and to propose a simulated model of infection contributing to a better understanding of COVID-19 pathogenesis. SARS-CoV-2 – host interactome allowed to mirror likely mechanisms of infections in different subcellular districts.</p>
<p id="P23">The high likelihood of our model to <italic>in vivo</italic> real mechanisms strengths the representative power of the interactome and the explorative algorithm to simulate biological processes.</p>
<p id="P24">Moreover, the proximity among specific viral proteins into the network, such as nsp7, nsp8, nsp9, nsp10, nsp12, nsp13, nsp14 involved in the viral RNA replication, can be a good way to investigate their possible function in viral infection. The closeness among S, nsp5, nsp16, ORF9b in the network is difficult to interpret, but S, nsp5 and ORF9b, along with N, had significant positive responses of IgG antibody in sera of COVID-19 patients (<xref ref-type="bibr" rid="R31">31</xref>). In SARS-CoV infected cell culture, the location of nsp2 in the cytoplasm and to some extent in the nucleus, as well as ORF3a, ORF7b, ORF6 and M in ER, seems to be consistent with their location among nuclear and cytoplasmatic, and ER proteins respectively (<xref ref-type="bibr" rid="R32">32</xref>).</p>
<p id="P25">The involvement of proteasome and ubiquitination pathways, along with RNA replication, represent the principal pathways activated for assembly and replication of SARS-CoV-2 (<xref ref-type="bibr" rid="R18">18</xref>). In fact, strong increases in RNA-modifying proteins were revealed in cell culture after infection with SARS-CoV-2 (<xref ref-type="bibr" rid="R33">33</xref>). The ubiquitin proteasome system deletes viral proteins to control the infection, but the virus can use them for its propagation (<xref ref-type="bibr" rid="R34">34</xref>).</p>
<p id="P26">The interactomes, built around a single protein of SARS-CoV-2, allowed to draw effects on cell, involving specific pathways. Vesicular transport mechanism by SNARE interactions, identified for NS7b, is used by pathogens to penetrate host cells through their membranes and in particular in SARS-CoV (<xref ref-type="bibr" rid="R35">35</xref>, <xref ref-type="bibr" rid="R36">36</xref>).</p>
<p id="P27">The pathways showed in ORF3a and ORF8 interactomes suggested a possible modulation of coagulation cascade and cardiovascular pathology in COVID-19 and the involvement in Cytokine storm and water homeostasis in endothelial tissue, respectively.</p>
<p id="P28">Binding of ORF3a and ORF8 to TGF-β-associated factors (TGFB1, TGFB2, LTBP1, TGFBR2, FURIN, BAMBI) supports a strong involvement to begging pro-inflammation state, while the direct interactions between ORF8 and components of Coagulation pathway, such as FGB, FGA, C5, PLAU, PROS1, SERPINE1, PLAT and CLU (<xref ref-type="bibr" rid="R17">17</xref>, <xref ref-type="bibr" rid="R18">18</xref>) suggest a modulation of coagulation cascade by SARS-CoV-2.</p>
<p id="P29">Although the biological function of the ORF8 protein of SARS-CoV-2 remains unclear, the role of ORF8 in severe COVID-19 outcome might be supported by SARS-CoV-2 variant with a 382-nucleotide deletion (Δ382) found in Singapore in January-February 2020 linked to mild forms of COVID-19. This deletion truncates open reading frame 7b and locks ORF8 transcription and would be associated to less cytokine releasing during the acute phase of infection (<xref ref-type="bibr" rid="R37">37</xref>, <xref ref-type="bibr" rid="R38">38</xref>).</p>
<p id="P30">The systemic inflammatory response and the relied endothelial dysfunction might be responsible for the microvascular injuries resulting in the formation of microthrombi, as well as a featuring microvascular thrombosis and hemorrhage pathology, viewed in lung of COVID-19 patients (<xref ref-type="bibr" rid="R11">11</xref>). The main pathways described in ORF3a and ORF8 interactomes, are consistent with the microvascular injuries and the development of cardiovascular complications i. e. heart failure, myocarditis, pericarditis, vasculitis and cardiac arrhythmias observed in COVID-19 patients(<xref ref-type="bibr" rid="R39">39</xref>). Such featuring symptoms, suggest specific mechanisms of host-virus interactions, and reinforce the role of ORF3a and ORF8 in the COVID-19 pathogenesis.</p>
<p id="P31">To study the pathogenesis of COVID-19 in systemic context, Bradykinin Storm was investigated by the interactome approach. We showed NS7b and ORF3a interacting with ECE1, which can inactivate BK (<xref ref-type="bibr" rid="R40">40</xref>). Such observation suggests specific mechanisms of host-virus interactions, occurring in severe COVID-19 patients and reinforce the role of ORF3a to enhance the bradykinin dysregulation.</p>
<p id="P32">These host-virus interactions could enhance a better viral fitness during the infection, as suggested by the interaction already observed with SARS-CoV between NS7b in ECE1(<xref ref-type="bibr" rid="R18">18</xref>).</p>
<p id="P33">This interaction system might suggest a hypothesis that can explain the possible enhancing effect on Bradykinin Storm in COVID-19: the locking of ECE1 activity due to NS7b and especially ORF3a interaction, could reduce the activation of the vasoconstrictor endotelin-1, and amplify the vasodilatation effect of BK. The ECE1 gene is much more expressed in all the tissues than ACE2 and ACE, especially in the lungs, where ECE1 is 128 fold and 3.8 fold expressed compared to ACE2 and ACE, respectively (<xref ref-type="bibr" rid="R41">41</xref>).</p>
<p id="P34">Similar to the angiotensin peptides, BK is produced from an inactive pre-protein Kininogen-1 through the activation by the serine protease kallikrein (<xref ref-type="bibr" rid="R42">42</xref>). Furthermore, the excess of BK can lead to vasodilatation, hypotension and hypokalaemia (<xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R43">43</xref>), which is associated with arrhythmia (<xref ref-type="bibr" rid="R44">44</xref>, <xref ref-type="bibr" rid="R45">45</xref>). All these clinical conditions have been widely reported in COVID-19 patients (<xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R47">47</xref>). It is also notable that many of the other symptoms reported for COVID-19 (myalgia, fatigue, nausea, vomiting, diarrhoea, anorexia, headaches, decreased cognitive function) are remarkably similar to other hyper-BK-conditions that lead to vascular hyperpermeabilization (<xref ref-type="bibr" rid="R48">48</xref>). Moreover, the activation of BK is strongly linked to coagulation: active F12 activates plasma kallikrein (PK), that liberates bradykinin by cleavage (<xref ref-type="bibr" rid="R49">49</xref>). The direct interactions between ORF8 and two plasminogen activators, PLAU and PLAT, and Plasminogen activator inhibitor 1, SERPINE1, bulk proteins of Plasminogen Activator System and involved in lung injuries and neuroinflammation (<xref ref-type="bibr" rid="R31">31</xref>, <xref ref-type="bibr" rid="R32">32</xref>), would suggest a modulating effect of ORF8 on Bradykinin Storm.</p>
<p id="P35">Moreover, inflammatory conditions highly induce an up-regulation of Bradykinin receptor B1 (BKB1R) (<xref ref-type="bibr" rid="R50">50</xref>). The results of our network-based model for pathogenesis of SARS-CoV-2 mirror likely clinical manifestations in severe COVID-19 patients, noting that analysis of published data about COVID-19 allows to synthesise and describe complex aspect of pathogenesis, as reported for inflammatory cytokines storm in COVID-19-induced respiratory failure (<xref ref-type="bibr" rid="R16">16</xref>).</p>
<sec id="S7">
<title>Limitations</title>
<p id="P36">There are many experimental platforms for deriving such physical interactions, such as Affinity purification mass-spectrometry (AP-MS) and yeast-two-hybrid (Y2H), which enable the accurate identification of interactions with a relatively long time.</p>
<p id="P37">The scenario reported in this study refers to few experimental data available on public databases and could be different respect to real phenotypes of COVID-19 patients.</p>
<p id="P38">The pathways’ analysis did not consider tissue and cell type diversity. Finally, the low threshold established for the number of nodes found by RWR (200) limited the reconstruction of the entire pathways. However, this was a software-imposed threshold. Although such network-based approach showed great potential in identifying mechanisms not yet observed, experimental tests will be necessary to confirm what we have described.</p>
</sec>
<sec id="S8" sec-type="conclusions">
<title>Conclusion</title>
<p id="P39">We developed a network-based model for SARS-CoV-2 infection, which could be a framework for pathogenic evaluation of specific clinical outcomes.</p>
<p id="P40">Here, the PPI interactomes were used to identify mechanistic processes of the viral molecular machinery during SARS-CoV-2 infection, for viral survival and replication within the host. With this knowledge, proteins interactions crucial for pathogenesis could be discerned. We identified different host response induced by specific proteins of SARS-CoV-2, underlining the important role of ORF3a and ORF8 in phenotypes of severe COVID-19 patients. The interactome approach applied to identification of biological reactions around Kininogen-1, allowed to view NS7b and ORF3a interactions with ECE1, which might have a role to enhance Bradykinin storm. This network-based model of SARS-CoV-2 - host interaction could guide to develop novel treatments against specific viral proteins, such as monoclonal antibodies.</p>
</sec>
</sec>
<sec id="S9" sec-type="methods | materials">
<title>Methods and Materials</title>
<p id="P41">The virus–host interactome was made by merging SARS-CoV-2 –host protein-protein interaction (PPI) data from Intact (<xref ref-type="bibr" rid="R51">51</xref>), with data from human PPI databases, such as BioGrid, InnateDB-All, IMEx, IntAct, MatrixDB, MBInfo, MINT, Reactome, Reactome-FIs, UniProt, VirHostNet, BioData, obtained by R packages PSICQUIC and biomaRt (<xref ref-type="bibr" rid="R52">52</xref>, <xref ref-type="bibr" rid="R53">53</xref>). For SARS-CoV-2 - host interaction experimentally obtained, 1407 protein interactors and 2305 interactions were download from IntAct at 12 September 2020. 28 SARS-CoV-2 proteins are used for all the analyses: E, M, N, S, nsp1, nsp2, nsp3, nsp4, nsp5, nsp6, nsp7, nsp8, nsp9, nsp10, nsp12, nsp13, nsp14, nsp15, nsp16, ORF1a, ORF3a, ORF6, ORF7a, NS7b, ORF8, ORF9b, ORF10, ORF14.</p>
<p id="P42">To obtain functional information about PPI ex vitro, to simulate biological reactions in infected cells and to explore cell response against viral infection, we employed a Random walk with restart (RWR) algorithm, a state-of-the-art guilt-by-association approach(<xref ref-type="bibr" rid="R54">54</xref>). This algorithm allows to establish a proximity network from a given protein (seed), to study its functions, based on the premise that nodes related to similar functions tend to lie close to each other in the network. For this study, two types of interactome were performed: the whole SARS-CoV-2 -host interactome and an interactome per single SARS-COV-2 protein.</p>
<p id="P43">In the first imputation, every protein of SARS-CoV-2 proteome was used as seeds, with the limit of 200 closest host’s proteins to every SAR-CoV-2 protein, every protein of SARS-CoV-2 proteome was chosen as seeds for Random walk with restart, imposing the limit of 200 closest host proteins to every SARS-CoV-2 proteins. This analysis allowed to design SARS-COV-2-host interactome, where the different colours correspond to the localization of the proteins within the cell.</p>
<p id="P44">For the second kind of interactome, one SARS-CoV-2 per time was used as seed, lowering to closest 50 proteins in order to define the induced biological response as better as possible.</p>
<p id="P45">For each node, a score was computed as a measure of proximity to the seed protein (<xref ref-type="bibr" rid="R23">23</xref>). In total, a large PPI interaction database was assembled, including 13334 nodes and 73584 interactions. Graphical representations of networks were performed by GEPHI 0. 9. 2 (<xref ref-type="bibr" rid="R55">55</xref>). To identify hub protein in the SARS-CoV-2 - host interactome, the values of betweenness centrality and degree were plotted. Betweenness centrality score measure how a specific node is in-between other nodes and then can be considered a hub, while the degree of node corresponds to number of connections.</p>
<p id="P46">Pathways of proteins involved in host response were tested by gene enrichment analysis on Kyoto Encyclopaedia of Genes and Genomes (KEGG) human pathways and WikiPathways databases (<xref ref-type="bibr" rid="R56">56</xref>). To allow gathering of results for every running, the R package enrichR was used, an R interface to web-based tool 'Enrichr' for analysing gene sets (<xref ref-type="bibr" rid="R57">57</xref>). The Enrichr analysis was performed using these statistical parameters: p-value (Fisher exact test), q-value (adjusted p-value for false discovery rate, FDR). Results for KEGG and WikiPathways were considered significant with a revised p-value &lt; 0. 05. To infer pathways involved in single viral interactome, gene enrichment analyses for each viral interactome were collected along with p-values, as reported in enrichR package output. P-values of every single enrichment analyses were transformed by the function x = − log10 (p-value) and the 5% of x values were plotted on heatmap by R package pheatmap (<xref ref-type="bibr" rid="R58">58</xref>).</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary Figures and tables</label>
<media xlink:href="EMS103585-supplement-Supplementary_Figures_and_tables.pdf" mimetype="application" mime-subtype="pdf" id="N66407" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S10">
<title>Acknowledgments</title>
<p>We gratefully acknowledge: Collaborators Members of INMI COVID-19 study group;</p>
<p>COVID 19 INMI Network Medicine for IDs Study Group: Abbate Isabella, Agrati Chiara, Al Moghazi Samir, Ascoli Bartoli Tommaso, Bartolini Barbara, Capobianchi Maria Rosaria, Capone Alessandro, Goletti Delia, Rozera Gabriella, Nisii Carla, Gagliardini Roberta, Ciccosanti Fabiola, Fimia Gian Maria, Nicastri Emanuele, Giombini Emanuela, Lanini Simone, D'Abramo Alessandra, Rinonapoli Gabriele, Girardi Enrico, Montaldo Chiara, Marconi Raffaella, Addis Antonio, Maron Bradley, Bianconi Ginestra, De Meulder Bertrand, Kennedy Jason, Khader Shabaana Abdul, Luca Francesca, Maeurer Markus, Piacentini Mauro, Merler Stefano, Pantaleo Giuseppe, Rafick-Pierre Sekaly, Sanna Serena, Segata Nicola, Zumla Alimuddin, Messina Francesco, Vairo Francesco, Lauria Francesco Nicola, Ippolito Giuseppe.</p>
<sec id="S11">
<title>Funding</title>
<p>National Institute for Infectious Diseases Lazzaro Spallanzani–IRCCS received financial support funded by Italian Ministry of Health, grants: Ricerca Corrente program 1- Emerging and re-emerging infections; It-IDRIN, CCR-2017-23669075; and by projects COVID-2020-12371675 and COVID-2020-12371817.</p>
<p>This work was supported also by Findus Italia, part of the Nomad Foods.</p>
<p>Giuseppe Ippolito and Alimuddin Zumla are co-Principal Investigators of the Pan-African Network on Emerging and Re-Emerging Infections (PANDORA-ID-NET – <ext-link ext-link-type="uri" xlink:href="https://www.pandora-id.net/">https://www.pandora-id.net/</ext-link>) funded by the European and Developing Countries Clinical Trials Partnership the EU Horizon 2020 Framework Programme. Sir Zumla is in receipt of a National Institutes of Health Research senior investigator award and is a Mahathir Science Award Laurete.</p>
</sec>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>PPI</term>
<def>
<p>Protein-Protein Interactions</p>
</def>
</def-item>
<def-item>
<term>SARS-CoV</term>
<def>
<p>Severe Acute Respiratory Syndrome Coronavirus</p>
</def>
</def-item>
<def-item>
<term>SARS-CoV-2</term>
<def>
<p>Severe Acute Respiratory Syndrome Coronavirus 2</p>
</def>
</def-item>
<def-item>
<term>H-CoV</term>
<def>
<p>Human Coronavirus</p>
</def>
</def-item>
<def-item>
<term>COVID-19</term>
<def>
<p>Coronavirus Disease 19</p>
</def>
</def-item>
<def-item>
<term>ORF</term>
<def>
<p>Open Reading Frame</p>
</def>
</def-item>
<def-item>
<term>RWR</term>
<def>
<p>Random walk with restart</p>
</def>
</def-item>
<def-item>
<term>FDR</term>
<def>
<p>False Discovery Rate</p>
</def>
</def-item>
<def-item>
<term>ER</term>
<def>
<p>Endoplasmic reticulum</p>
</def>
</def-item>
<def-item>
<term>Nsp</term>
<def>
<p>non-structural protein</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn fn-type="con" id="FN1">
<p id="P47">
<bold>Authors’ contributions</bold>
</p>
<p id="P48">Conceptualization: F. M., F. N. L. Data curation: F. M., E. G., Formal analysis: F. M. Funding acquisition: M. R. C., G. I. Investigation: F. M., F. N. L. Methodology: F. M. Resources: M. R. C., G. I. Software: F. M., Supervision: F. N. L. Validation: F. M. Visualization: F. M. E. G. Writing ± original draft: F. M., E. G., F. N. L. Writing ± review &amp; editing: F. M., E. G., M. R. C., F. N. L, C. M. All authors reviewed and approved the manuscript.</p>
</fn>
<fn id="FN2" fn-type="conflict">
<p id="P49">
<bold>Author declarations</bold>
</p>
<p id="P50">All authors have an interest in infectious diseases epidemics and public health. Authors declare no conflicts of interest.</p>
</fn>
<fn id="FN3">
<p id="P51">
<bold>Consent for publication</bold>
</p>
<p id="P52">Not applicable.</p>
</fn>
<fn id="FN4">
<p id="P53">
<bold>Ethics approval and consent to participate</bold>
</p>
<p id="P54">Not applicable.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="book">
<collab>European Centre for Disease Prevention and Control</collab>
<source>Clinical characteristics of COVID-19</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolff</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hickey</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Marschollek</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Risk factors for Covid-19 severity and fatality: a structured literature review</article-title>
<source>Infection</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1007/s15010-020-01509-1</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolff</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Melia</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Snijder</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Barcena</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Double-Membrane Vesicles as Platforms for Viral Replication</article-title>
<source>Trends in microbiology</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.tim.2020.05.009</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title>
<source>Nature</source>
<year>2020</year>
<volume>579</volume>
<fpage>270</fpage>
<lpage>273</lpage>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hillen</surname>
<given-names>HS</given-names>
</name>
<etal/>
</person-group>
<article-title>Structure of replicating SARS-CoV-2 polymerase</article-title>
<source>Nature</source>
<year>2020</year>
<volume>584</volume>
<fpage>154</fpage>
<lpage>156</lpage>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>te Velthuis</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>van den Worm</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Snijder</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<article-title>The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension</article-title>
<source>Nucleic acids research</source>
<year>2012</year>
<volume>40</volume>
<fpage>1737</fpage>
<lpage>1747</lpage>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kleine-Weber</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pohlmann</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells</article-title>
<source>Molecular cell</source>
<year>2020</year>
<volume>78</volume>
<fpage>779</fpage>
<lpage>784</lpage>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<fpage>271</fpage>
<lpage>280</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garvin</surname>
<given-names>MR</given-names>
</name>
<etal/>
</person-group>
<article-title>A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm</article-title>
<source>eLife</source>
<year>2020</year>
<volume>9</volume>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montone</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Iannaccone</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Meucci</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Gurgoglione</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Niccoli</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Myocardial and Microvascular Injury Due to Coronavirus Disease 2019</article-title>
<source>European cardiology</source>
<year>2020</year>
<volume>15</volume>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGonagle</surname>
<given-names>D</given-names>
</name>
<name>
<surname>O'Donnell</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Sharif</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Emery</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bridgewood</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia</article-title>
<source>The Lancet Rheumatology</source>
<year>2020</year>
<volume>2</volume>
<fpage>e437</fpage>
<lpage>e445</lpage>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China</article-title>
<source>JAMA cardiology</source>
<year>2020</year>
<volume>5</volume>
<fpage>802</fpage>
<lpage>810</lpage>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019</article-title>
<source>European heart journal</source>
<year>2020</year>
<volume>41</volume>
<fpage>2070</fpage>
<lpage>2079</lpage>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)</article-title>
<source>JAMA cardiology</source>
<year>2020</year>
<volume>5</volume>
<fpage>811</fpage>
<lpage>818</lpage>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>ZC</given-names>
</name>
<etal/>
</person-group>
<article-title>Incidence of myocardial injury in coronavirus disease 2019 (COVID-19): a pooled analysis of 7,679 patients from 53 studies</article-title>
<source>Cardiovascular diagnosis and therapy</source>
<year>2020</year>
<volume>10</volume>
<fpage>667</fpage>
<lpage>677</lpage>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leisman</surname>
<given-names>DE</given-names>
</name>
<etal/>
</person-group>
<article-title>Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes</article-title>
<source>Lancet Respiratory Medicine</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30404-5</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>DE</given-names>
</name>
<etal/>
</person-group>
<article-title>A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</article-title>
<source>Nature</source>
<year>2020</year>
<volume>583</volume>
<fpage>459</fpage>
<lpage>468</lpage>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stukalov</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV</article-title>
<source>BioRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hazra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chaudhuri</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Tiwary</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based metaanalysis</article-title>
<source>Life sciences</source>
<year>2020</year>
<volume>257</volume>
<comment>118096</comment>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19</article-title>
<source>ChemRxiv : the preprint server for chemistry</source>
<year>2020</year>
<comment>10.26434/chemrxiv.12579137.v1</comment>
<pub-id pub-id-type="doi">10.26434/chemrxiv.12579137.v1</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Law</surname>
<given-names>JN</given-names>
</name>
<etal/>
</person-group>
<article-title>Identifying Human Interactors of SARS-CoV-2 Proteins and Drug Targets for COVID-19 using Network-Based Label Propagation</article-title>
<source>bioarxiv arXiv:2006.01968</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srinivasan</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins</article-title>
<source>Viruses</source>
<year>2020</year>
<volume>12</volume>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messina</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection</article-title>
<source>Journal of translational medicine</source>
<year>2020</year>
<volume>18</volume>
<fpage>233</fpage>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barabasi</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Gulbahce</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Loscalzo</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Network medicine: a network-based approach to human disease</article-title>
<source>Nature reviews Genetics</source>
<year>2011</year>
<volume>12</volume>
<fpage>56</fpage>
<lpage>68</lpage>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menche</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<collab>Disease networks</collab>
<article-title>Uncovering disease-disease relationships through the incomplete interactome</article-title>
<source>Science</source>
<year>2015</year>
<volume>347</volume>
<comment>1257601</comment>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ostaszewski</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms</article-title>
<source>Scientific data</source>
<year>2020</year>
<volume>7</volume>
<fpage>136</fpage>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazein</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms</article-title>
<source>NPJ systems biology and applications</source>
<year>2018</year>
<volume>4</volume>
<fpage>21</fpage>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ostaszewski</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>COVID-19 Disease Map, a computational knowledge repository of SARS-CoV-2 virus-host interaction mechanisms</article-title>
<source>bioRxiv</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.10.26.356014</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pena</surname>
<given-names>ALB</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Severo</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Simoes</surname>
<given-names>ESAC</given-names>
</name>
</person-group>
<article-title>COVID-19 related coagulopathy: what is known up to now</article-title>
<source>Current medicinal chemistry</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.2174/0929867327666201005112231</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira-Gomes</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>In severe COVID-19, SARS-CoV-2 induces a chronic, TGF-ß-dominated adaptive immune response</article-title>
<source>medarXiv</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.09.04.20188169</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>HW</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses</article-title>
<source>Nature communications</source>
<year>2020</year>
<volume>11</volume>
<fpage>3581</fpage>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>von Brunn</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome</article-title>
<source>PloS one</source>
<year>2007</year>
<volume>2</volume>
<fpage>e459</fpage>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bojkova</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Proteomics of SARS-CoV-2-infected host cells reveals therapy targets</article-title>
<source>Nature</source>
<year>2020</year>
<volume>583</volume>
<fpage>469</fpage>
<lpage>472</lpage>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Pleiotropic roles of the ubiquitin-proteasome system during viral propagation</article-title>
<source>Life sciences</source>
<year>2018</year>
<volume>207</volume>
<fpage>350</fpage>
<lpage>354</lpage>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wesolowski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Paumet</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>SNARE motif: a common motif used by pathogens to manipulate membrane fusion</article-title>
<source>Virulence</source>
<year>2010</year>
<volume>1</volume>
<fpage>319</fpage>
<lpage>324</lpage>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core</article-title>
<source>The Journal of biological chemistry</source>
<year>2004</year>
<volume>279</volume>
<fpage>49414</fpage>
<lpage>49419</lpage>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>YCF</given-names>
</name>
<etal/>
</person-group>
<article-title>Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2</article-title>
<source>mBio</source>
<year>2020</year>
<volume>11</volume>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>BE</given-names>
</name>
<etal/>
</person-group>
<article-title>Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study</article-title>
<source>Lancet</source>
<year>2020</year>
<volume>396</volume>
<fpage>603</fpage>
<lpage>611</lpage>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magro</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases</article-title>
<source>Translational research : the journal of laboratory and clinical medicine</source>
<year>2020</year>
<volume>220</volume>
<fpage>1</fpage>
<lpage>13</lpage>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Padilla</surname>
<given-names>BE</given-names>
</name>
<etal/>
</person-group>
<article-title>Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and beta-arrestins</article-title>
<source>The Journal of cell biology</source>
<year>2007</year>
<volume>179</volume>
<fpage>981</fpage>
<lpage>997</lpage>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="book">
<collab>The GTEx Consortium</collab>
<source>The GTEx Consortium atlas of genetic regulatory effects across human tissues</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmaier</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities</article-title>
<source>Journal of thrombosis and haemostasis : JTH</source>
<year>2016</year>
<volume>14</volume>
<fpage>28</fpage>
<lpage>39</lpage>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>DD</given-names>
</name>
<etal/>
</person-group>
<article-title>Bradykinin Stimulates Renal Na(+) and K(+) Excretion by Inhibiting the K(+) Channel (Kir4.1) in the Distal Convoluted Tubule</article-title>
<source>Hypertension</source>
<year>2018</year>
<volume>72</volume>
<fpage>361</fpage>
<lpage>369</lpage>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kjeldsen</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Hypokalemia and sudden cardiac death</article-title>
<source>Experimental and clinical cardiology</source>
<year>2010</year>
<volume>15</volume>
<fpage>e96</fpage>
<lpage>99</lpage>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skogestad</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Aronsen</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Hypokalemia-Induced Arrhythmias and Heart Failure: New Insights and Implications for Therapy</article-title>
<source>Frontiers in physiology</source>
<year>2018</year>
<volume>9</volume>
<fpage>1500</fpage>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>
<source>Lancet</source>
<year>2020</year>
<volume>395</volume>
<fpage>497</fpage>
<lpage>506</lpage>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China</article-title>
<source>Jama</source>
<year>2020</year>
<volume>323</volume>
<fpage>1061</fpage>
<lpage>1069</lpage>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van de Veerdonk</surname>
<given-names>FL</given-names>
</name>
<etal/>
</person-group>
<article-title>Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome</article-title>
<source>eLife</source>
<year>2020</year>
<volume>9</volume>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hofman</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>de Maat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hack</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Bradykinin: Inflammatory Product of the Coagulation System</article-title>
<source>Clinical reviews in allergy &amp; immunology</source>
<year>2016</year>
<volume>51</volume>
<fpage>152</fpage>
<lpage>161</lpage>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qadri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Kinin B1 receptors as a therapeutic target for inflammation</article-title>
<source>Expert opinion on therapeutic targets</source>
<year>2018</year>
<volume>22</volume>
<fpage>31</fpage>
<lpage>44</lpage>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hermjakob</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>IntAct: an open source molecular interaction database</article-title>
<source>Nucleic acids research</source>
<year>2004</year>
<volume>32</volume>
<fpage>D452</fpage>
<lpage>455</lpage>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aranda</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>PSICQUIC and PSISCORE: accessing and scoring molecular interactions</article-title>
<source>Nature methods</source>
<year>2011</year>
<volume>8</volume>
<fpage>528</fpage>
<lpage>529</lpage>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smedley</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>BioMart--biological queries made easy</article-title>
<source>BMC genomics</source>
<year>2009</year>
<volume>10</volume>
<fpage>22</fpage>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valdeolivas</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Random walk with restart on multiplex and heterogeneous biological networks</article-title>
<source>Bioinformatics</source>
<year>2019</year>
<volume>35</volume>
<fpage>497</fpage>
<lpage>505</lpage>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Bastian</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Heymann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jacomy</surname>
<given-names>M</given-names>
</name>
</person-group>
<source>Gephi: an open source software for exploring and manipulating networks</source>
<conf-name>International AAAI Conference on Weblogs and Social Media</conf-name>
<year>2009</year>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slenter</surname>
<given-names>DN</given-names>
</name>
<etal/>
</person-group>
<article-title>WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research</article-title>
<source>Nucleic acids research</source>
<year>2018</year>
<volume>46</volume>
<fpage>D661</fpage>
<lpage>D667</lpage>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuleshov</surname>
<given-names>MV</given-names>
</name>
<etal/>
</person-group>
<article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title>
<source>Nucleic acids research</source>
<year>2016</year>
<volume>44</volume>
<fpage>W90</fpage>
<lpage>97</lpage>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Kolde</surname>
<given-names>R</given-names>
</name>
</person-group>
<source>pheatmap: Pretty heatmaps [Software]</source>
<year>2015</year>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Workflow to describe SARS-CoV-2 host interactome analysis based on PPI data.</p>
</caption>
<graphic xlink:href="EMS103585-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>A) PPI interactome, based on human PPI and SARS-CoV-2-host interactions, with top 200 closest proteins identified by RWR, using together 28 proteins of SARS-CoV-2 as seeds for only one RWR run. Different colours of node and edges represent different locations in the cell, which are reported in the legend and in S-Table 1. This network was represented by Force Atlas algorithm. B) KEGG human pathway and WikiPathways Gene Enrichment analyses for 200 proteins identified by RWR algorithm using together 28 proteins of SARS-CoV-2.</p>
</caption>
<graphic xlink:href="EMS103585-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Heatmap reporting top 5% smallest P values of Gene Enrichment analysis on list of proteins, obtained by every interactome of single viral seed. The values were reported as -Log10 (p value). A) P values of Gene Enrichment based on KEGG 2019. B) P values of Gene Enrichment based on WikiPathways 2019.</p>
</caption>
<graphic xlink:href="EMS103585-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>PPI interactome based on human PPI and SARS-CoV-2-host interactions, with top 200 closest proteins identified by RWR, using Kininogen-1 as seed. A) PPI Intercatome, where larger nodes and edges in red represent interactions via NS7b and ORF3a-ECE1-KNG1 (BK). The nodes in red are human proteins, while the nodes in green are virus proteins. B) KEGG human pathway and WikiPathways Gene Enrichment analyses for 200 proteins closest to KNG-1. C) PPI interactome, where proteins belonged to Human Complement System WP2806 (modes in purple) and Complement and coagulation cascades (nodes in blue) pathways were highlighted. The proteins belonged to both pathways were marked in light blue. The nodes in red are human proteins, while the nodes in green are virus proteins.</p>
</caption>
<graphic xlink:href="EMS103585-f004"/>
</fig>
</floats-group>
</article>
